posted on Aug 03 by MedPage Today OB/Gyn in the Uncategorized category
WASHINGTON (MedPage Today) -- The FDA has ordered new labeling for fluconazole (Diflucan), warning that multiple, high doses of the antifungal by pregnant women may increase the risk of birth defects.